Blogging About Critters Since 2007

Tuesday, December 7, 2010

Positive Responses from Animal Testers?

I guess it depends on how much you believe them....

The article from UPI is below in its entirety.
Drug and chemical companies say they endorse a Europe-wide initiative intended to eventually end the use of animals in research and safety testing.

Experts from companies including drug giants AstraZeneca, Procter & Gamble, Unilever and cosmetics firm L'Oreal say that soon the safety testing of new drugs and chemical products will use new technologies, including cell cultures and computer models, rather than living animals, The Daily Telegraph in Britain reported.

A report published by a panel of experts from industry, academic institutions and regulatory bodies supports an initiative aimed at finding alternatives to animal research.

"Today we are at a new biological milestone, where we could, with sufficient international and political support, ... produce the means and the technology to test and assess the human and environmental risk of tens of thousands of chemicals per year without using animals," the report says.

Testing a single chemical takes up to five years, involves 800 rodents and costs $3.8 million. Robotic alternatives could test 350 chemicals in less than a week at a fraction of the cost, the report says.

"Endorsement from cross-sector, independent experts provides a tremendous boost to European Union and international efforts to revolutionize the science of safety testing," Troy Seidle, director of research for Humane Society International, said.

"The fact that industry is prepared to come to the table to meet with regulators and say they are prepared to do development, invest resources and change the way we do things shows this is a real possibility that is not just pie in the sky."

1 comment:

Andrew Heaton said...


On the face of it at least, this is wonderful news.

Whilst I am not convinced of the sincerity of the pharmaceutical industry in wanting to end animal testing based on altruistic grounds, their desire to save on time and costs is beyond question. If robotic methods can deliver results of the same reliability, then drug makers will hopefully adopt these as a way of cost reduction and speedier time to market. If that happens, animals will be spared in the future.